Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Spencer

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Prenatal Diagnosis|December 13, 2002
Uptake of prenatal screening for chromosomal anomalies: impact of test results in a previous pregnancyKevin Spencer
Fetal Diagnosis and Therapy|August 18, 2010
First and second trimester markers of fetal aneuploidy in pregnant women with HIV infectionKevin Spencer
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|February 10, 2007
Aneuploidy screening in the first trimesterKevin Spencer
Annals of Clinical Biochemistry|March 29, 2003
The influence of different sample collection types on the levels of markers used for Down's syndrome screening as measured by the Kryptor Immunosassay systemKevin Spencer
Annals of Clinical Biochemistry|April 2, 2005
First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assaysKevin Spencer
American Journal of Obstetrics and Gynecology|September 3, 2013
The role of maternal serum α-fetoprotein in screening for open spina bifida at 11-13 weeksKevin Spencer
Prenatal Diagnosis|July 30, 2013
First trimester detection of double aneuploidy involving autosomes and sex chromosomes using combined biochemical and ultrasound screeningKevin Spencer
Prenatal Diagnosis|October 16, 2002
Between pregnancy biological variability of first trimester markers of Down syndrome and the implications for screening in subsequent pregnancies: an issue revisitedKevin Spencer
Clinical Chemistry|February 28, 2002
Point-of-care screening for chromosomal anomalies in the first trimester of pregnancyKevin Spencer
Prenatal Diagnosis|March 29, 2002
Accuracy of Down syndrome risks produced in a first-trimester screening programme incorporating fetal nuchal translucency thickness and maternal serum biochemistryKevin Spencer
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Prenatal Diagnosis|December 13, 2002
Uptake of prenatal screening for chromosomal anomalies: impact of test results in a previous pregnancyKevin Spencer
Fetal Diagnosis and Therapy|August 18, 2010
First and second trimester markers of fetal aneuploidy in pregnant women with HIV infectionKevin Spencer
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|February 10, 2007
Aneuploidy screening in the first trimesterKevin Spencer
Annals of Clinical Biochemistry|March 29, 2003
The influence of different sample collection types on the levels of markers used for Down's syndrome screening as measured by the Kryptor Immunosassay systemKevin Spencer
Annals of Clinical Biochemistry|April 2, 2005
First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assaysKevin Spencer
American Journal of Obstetrics and Gynecology|September 3, 2013
The role of maternal serum α-fetoprotein in screening for open spina bifida at 11-13 weeksKevin Spencer
Prenatal Diagnosis|July 30, 2013
First trimester detection of double aneuploidy involving autosomes and sex chromosomes using combined biochemical and ultrasound screeningKevin Spencer
Prenatal Diagnosis|October 16, 2002
Between pregnancy biological variability of first trimester markers of Down syndrome and the implications for screening in subsequent pregnancies: an issue revisitedKevin Spencer
Clinical Chemistry|February 28, 2002
Point-of-care screening for chromosomal anomalies in the first trimester of pregnancyKevin Spencer
Prenatal Diagnosis|March 29, 2002
Accuracy of Down syndrome risks produced in a first-trimester screening programme incorporating fetal nuchal translucency thickness and maternal serum biochemistryKevin Spencer
Pageof 10